{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:30Z","timestamp":1787041650860,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119136","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:43:14Z","timestamp":1783600994000},"page":"119136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ER\u03b1 inhibitors with in vitro activity in breast cancer models"],"prefix":"10.1016","volume":"317","author":[{"given":"Ester","family":"Colarusso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmina","family":"Scala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Iazzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Pellecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Campiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bifulco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Irace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-9717","authenticated-orcid":false,"given":"Gianluigi","family":"Lauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119136_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/scbi.2001.0389","article-title":"Estrogen receptor and breast cancer","author":"Sommer","year":"2001","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2026.119136_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/092986713804999303","article-title":"Treatment of estrogen receptor-positive breast cancer","volume":"20","author":"Lumachi","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/dc.2840080508","article-title":"Estrogen and progesterone receptors in cytology: a comprehensive review","volume":"8","author":"Masood","year":"1992","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.ejmech.2026.119136_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12094-006-0089-6","article-title":"Molecular biology of breast cancer","volume":"8","author":"Mart\u00edn","year":"2006","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ejmech.2026.119136_bib5","article-title":"Role of estrogen receptors in health and disease","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2026.119136_bib6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119136_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/bcr81","article-title":"Estrogen receptor transcription and transactivation: basic aspects of estrogen action","volume":"5","author":"Nilsson","year":"2000","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119136_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112689","article-title":"Targeting estrogen receptor \u03b1 for degradation with PROTACs: a promising approach to overcome endocrine resistance","volume":"206","author":"Lin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114658","article-title":"An overview on Estrogen receptors signaling and its ligands in breast cancer","volume":"241","author":"Khan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib10","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/cmdc.202000473","article-title":"The quest for orally available selective estrogen receptor degraders (SERDs)","volume":"15","author":"Wang","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119136_bib11","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1021\/jm8004515","article-title":"Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion","volume":"51","author":"Kline","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib12","article-title":"Thiazolidin-4-one-based compounds interfere with the eicosanoid biosynthesis pathways by mPGES-1\/sEH\/5-LO multi-target inhibition","volume":"5","author":"Colarusso","year":"2022","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.ejmech.2026.119136_bib13","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3390\/molecules30102201","article-title":"Review of recent advances in Thiazolidin-4-One derivatives as promising antitubercular agents (2021\u2013Present)","volume":"30","author":"Drza\u0142","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119136_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116397","article-title":"Exploration of isoxazole analogs: synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling","volume":"271","author":"Hawash","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib15","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.3390\/molecules29174025","article-title":"Identification of novel bromodomain-containing protein 4 (BRD4) binders through 3D pharmacophore-based repositioning screening campaign","volume":"29","author":"Colarusso","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119136_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cplu.202400234","article-title":"Repositioning of small molecules through the inverse virtual screening in silico tool: case of benzothiazole-based inhibitors of soluble epoxide hydrolase (sEH)","author":"Gazzillo","year":"2024","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.ejmech.2026.119136_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cplu.202400339","article-title":"In silico design, chemical synthesis, biophysical and in vitro evaluation for the identification of 1\u2010Ethyl\u20101H\u2010Pyrazolo [3, 4\u2010b] pyridine\u2010based BRD9 binders","volume":"89","author":"Colarusso","year":"2024","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.ejmech.2026.119136_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202404218","article-title":"Unveiling new Triazoloquinoxaline\u2010Based PROTACs designed for the selective degradation of the ncBAF chromatin remodeling subunit BRD9","volume":"31","author":"Pierri","year":"2025","journal-title":"Chem.--Eur. J."},{"key":"10.1016\/j.ejmech.2026.119136_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129171","article-title":"Target identification by structure-based computational approaches: recent advances and perspectives","volume":"83","author":"De Vita","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119136_bib20","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/acs.jcim.9b00428","article-title":"Protein preparation automatic protocol for high-throughput inverse virtual screening: accelerating the target identification by computational methods","volume":"59","author":"De Vita","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119136_bib21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/np100935s","article-title":"Inverse virtual screening of antitumor targets: pilot study on a small database of natural bioactive compounds","volume":"74","author":"Lauro","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2026.119136_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/me.2002-0331","article-title":"A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment","volume":"17","author":"Liu","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejmech.2026.119136_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1225951","article-title":"Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future","volume":"14","author":"Yao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119136_bib25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acs.jmedchem.9b01293","article-title":"A potent and selective estrogen receptor degrader (SERD) for the treatment of estrogen-receptor-positive breast cancer","volume":"63","author":"El-Ahmad","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib26","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1021\/acs.jmedchem.0c01930","article-title":"Successful and unsuccessful prediction of human hepatic clearance for lead optimization","volume":"64","author":"Sodhi","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib27","series-title":"Dosage Forms: Innov. Future Perspect.","article-title":"In vitro drug metabolism studies using human liver microsomes","author":"Gajula","year":"2022"},{"key":"10.1016\/j.ejmech.2026.119136_bib28","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1016\/j.bmc.2012.03.072","article-title":"Inverse virtual screening allows the discovery of the biological activity of natural compounds","volume":"20","author":"Lauro","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib29","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib30","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib31","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib32","series-title":"Schr\u00f6dinger Release 2025-1: Glide","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119136_bib33","series-title":"Schr\u00f6dinger Release 2025-1","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119136_bib34","series-title":"Schrodinger Release 2025-1: Macromodel 13.1","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119136_bib35","series-title":"Gaussian 16, Revision C.01","author":"Frisch","year":"2016"},{"key":"10.1016\/j.ejmech.2026.119136_bib24","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1021\/acs.jcim.3c01920","article-title":"PharmaCore: the automatic generation of 3D structure-based pharmacophore models from protein\/ligand complexes","volume":"64","author":"De Vita","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119136_bib36","series-title":"Schr\u00f6dinger Release 2025-1: Phase, Schr\u00f6dinger LLC","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119136_bib37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2026.119136_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: a novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.119136_bib39","series-title":"Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing","year":"2006"},{"key":"10.1016\/j.ejmech.2026.119136_bib40","series-title":"Schr\u00f6dinger Release 2025-1: Desmond Molecular Dynamics System, D. E. Shaw Research","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119136_bib41","first-page":"175","article-title":"Comparison of [3H] Oestrodiol and [125I] Oestrodiol as Liganls for Oestrogen Recepror Deterdination","volume":"21","author":"Grill","year":"1983","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.ejmech.2026.119136_bib42","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/cells9061412","article-title":"Breast cancer chemotherapeutic options: a general overview on the preclinical validation of a multi-target ruthenium (III) complex lodged in nucleolipid nanosystems","volume":"9","author":"Ferraro","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119136_bib43","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.2147\/IJN.S453958","article-title":"Tuning peptide-based nanofibers for achieving selective doxorubicin delivery in triple-negative breast cancer","author":"Bellavita","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2026.119136_bib44","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.3390\/ijms24076473","article-title":"Triple negative breast cancer preclinical therapeutic management by a cationic ruthenium-based nucleolipid nanosystem","volume":"24","author":"Ferraro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119136_bib45","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/pharmaceutics17070918","article-title":"Ferroptosis among the antiproliferative pathways activated by a lipophilic ruthenium (III) complex as a candidate drug for triple-negative breast cancer","volume":"17","author":"Ferraro","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119136_bib46","series-title":"Cytochrome P450: in Vitro Methods Protocols","first-page":"229","article-title":"Cytochrome P450-mediated metabolic stability assay in liver microsomes","author":"Carione","year":"2021"},{"key":"10.1016\/j.ejmech.2026.119136_bib47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1021\/acs.jmedchem.5c02237","article-title":"Targeting class I histone deacetylases triggers antitumor responses in colorectal cancer in vitro and in vivo","volume":"69","author":"Carullo","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119136_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/acs.chemrestox.0c00224","article-title":"GLORYx: prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics","volume":"34","author":"de Bruyn Kops","year":"2020","journal-title":"Chem. Res. Toxicol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:01:57Z","timestamp":1787040117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"alternative-id":["S0223523426005817"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119136","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ER\u03b1 inhibitors with in vitro activity in breast cancer models","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119136"}}